Cabaletta Bio (CABA) Equity Average (2018 - 2025)

Cabaletta Bio's Equity Average history runs 8 years deep, the most recent figure standing at $125.8 million for Q4 2025.

• In Q4 2025, Equity Average fell 22.98% year-over-year to $125.8 million; the TTM figure through Dec 2025 stood at $125.8 million (down 22.98% YoY), while the FY2025 annual figure was $132.2 million, down 31.95% from the prior year.
• Equity Average was $125.8 million for Q4 2025 at Cabaletta Bio, down from $159.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $229.0 million in Q1 2024 to a low of $90.7 million in Q3 2022.
• Historically, Equity Average has averaged $139.6 million across 5 years, with a median of $129.3 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Equity Average jumped 133.43% in 2024, then plunged 40.19% in 2025.
• A 5-year view of Equity Average shows it stood at $117.3 million in 2021, then slipped by 18.83% to $95.2 million in 2022, then soared by 108.58% to $198.6 million in 2023, then dropped by 17.76% to $163.3 million in 2024, then declined by 22.98% to $125.8 million in 2025.
• The last three Equity Average figures came in at $125.8 million (Q4 2025), $159.0 million (Q3 2025), and $150.0 million (Q2 2025), per Business Quant data.